253 Medical Center Boulevard
MaSTherCell is a dynamic global cell and gene therapy Contract Development and Manufacturing Organization (CDMO), expanding its world presence with capabilities in the United States. MaSTherCell will be opening a new cell and gene therapy process development and production site in the Houston Metropolitan Area in the very near future. It will continue to combine academic and industry excellence to provide unparalleled quality manufacturing services to the cell therapy community. MaSTherCell’s teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies for critical diseases. MaSTherCell operates globally with additional operations in Europe, Israel, and Korea.
Why work at MaSTherCell?
1 article with MaSTherCell
MaSTherCell SA announces creation of a new commercial manufacturing facility for cell & gene therapies
The new facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell and gene therapy products.